Gynesonics
At Gynesonics our mission is to design and develop new and advanced technologies for improving women’s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. If your post, comment or message references an adverse event with the Sonata Treatment, we may contact you for more information. To monitor the safety of our products, we encourage you to report suspected adverse effects by calling Gynesonics at 844-723-5382 Monday – Friday 9 AM – 5 PM EST. Alternatively, you can report any serious side effects directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. We are committed to responding to your messages promptly. Our regular business hours are [Monday – Friday 9 AM – 5 PM EST. If a message is sent or a comment is made outside of regular business hours, or on weekends or company holidays, we will respond when business resumes. Please call 911 in the event of an emergency.
Growth Trajectory
Gynesonics, backed by Hologic's resources, has the opportunity to expand its market reach and increase adoption of the Sonata System through physician training, patient education, and strategic partnerships. Continuous development of SMART OS and refinement of the transcervical ablation techniques could drive further growth. International market expansion is also possible, albeit subject to regulatory variations.
Technical Challenges
Tech Stack
Team Size
Key Risks
Opportunities
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats